Equities, Investment & Market Trends
U.S. Congressional Committee Directs DEA and FDA to Enforce Against Unregulated Cannabinoid Products
A U.S. House committee has directed the DEA and FDA to take enforcement action against unregulated cannabinoid products deemed a consumer safety threat. T…
Access & Prescribing (Australia & Global)
Ghana Seeks Vermont Expertise to Develop Industrial Hemp and Medicinal Cannabis Marketplace
Ghana is collaborating with Vermont State University and industry experts to establish a low-potency cannabis marketplace, focusing on industrial hemp and…
Equities, Investment & Market Trends
Cannabis Banking Access: Operational Costs and Margin Erosion Beyond Account Availability
Explore how limited cannabis banking access creates hidden operational costs and erodes margins for operators. Understand the financial infrastructure cha…
Clinical Trials & Medical Research
Developing a Multicomponent Intervention to Enhance Medication Error Reporting in Hospitals
Explore the Medication Error Reporting Enhancement Program (MERP), a new theory-informed intervention designed to improve medication error reporting among…
Industrial Hemp & Advanced Manufacturing
Market Intelligence Platforms Offer Critical Data for Industrial Hemp Sector, Including Germany Hemp Milk Market Analysis
Understand how market intelligence platforms like IndexBox deliver essential data for the industrial hemp sector, with analysis available for the Germany…
Access & Prescribing (Australia & Global)
US Federal Medical Cannabis Rescheduling: A Step Towards Policy Alignment, But Significant Gaps Remain
Explore the implications of the US federal medical cannabis rescheduling, a significant policy shift. Understand its impact on patients, providers, and th…
Cannabinoid Pharmacology
Medical Cannabis and Mental Health: Clarifying Research Gaps and the Call for Rescheduling
A recent Lancet Psychiatry review on medical cannabis for mental health highlights a scarcity of evidence, not ineffectiveness. Learn why researchers advo…
Clinical Trials & Medical Research
Oklahoma Senate Passes Ibogaine Clinical Trials Bill, Awaiting Governor’s Signature
The Oklahoma State Senate has passed House Bill 3834, authorizing state-funded ibogaine clinical trials for substance use and mental health disorders. Lea…
Access & Prescribing (Australia & Global)
Georgia Governor Signs SB 220, Expanding Medical Cannabis Access and Revising Potency Limits
Georgia Governor Brian Kemp signed SB 220, expanding medical cannabis access by adding qualifying conditions, allowing vaping for patients over 21, and re…
Clinical Trials & Medical Research
Preliminary Research Explores *Inonotus hispidus* in Renal Cell Carcinoma Pathways
New research investigates the potential of *Inonotus hispidus* in modulating pathways associated with renal cell carcinoma. Learn about preliminary findin…
